Biocon | Wikipedia audio article
Channel: wikipedia tts
Date: 16/01/2019

This is an audio version of the Wikipedia Article:
https://en.wikipedia.org/wiki/Biocon


00:02:12 1 History
00:06:53 2 Corporate Governance
00:12:03 3 Subsidiaries, Acquisitions and Strategic Global Alliances
00:12:16 3.1 Syngene International Pvt Ltd
00:13:07 3.2 Clinigene
00:13:28 3.3 BBPL
00:13:58 3.4 Biocon-AxiCorp
00:14:45 3.5 NeoBiocon
00:15:36 3.6 Biocon and Amylin
00:16:21 3.7 Biocon and IATRICa
00:17:16 3.8 Biocon and Mylan
00:17:56 3.9 Biocon and Optimer
00:18:25 3.10 Biocon and Vaccinex
00:19:12 3.11 Biocon and Abraxis
00:20:07 3.12 Biocon and Sandoz
00:20:46 4 Biocon Technology
00:21:02 5 Research &amp; Development Capabilities
00:21:16 5.1 Process sciences
00:22:00 5.2 Non-clinical research
00:22:27 5.3 Clinical research
00:23:10 6 Products
00:23:30 6.1 Diabetology
00:24:32 6.2 Nephrology
00:25:28 6.3 Oncology
00:26:27 6.4 Cardiology
00:27:14 6.5 Other conditions
00:27:36 7 Growth drivers



Listening is a more natural way of learning, when compared to reading. Written language only began at around 3200 BC, but spoken language has existed long ago.

Learning by listening is a great way to:
- increases imagination and understanding
- improves your listening skills
- improves your own spoken accent
- learn while on the move
- reduce eye strain

Now learn the vast amount of general knowledge available on Wikipedia through audio (audio article). You could even learn subconsciously by playing the audio while you are sleeping! If you are planning to listen a lot, you could try using a bone conduction headphone, or a standard speaker instead of an earphone.

Listen on Google Assistant through Extra Audio:
https://assistant.google.com/services/invoke/uid/0000001a130b3f91
Other Wikipedia audio articles at:
https://www.youtube.com/results?search_query=wikipedia+tts
Upload your own Wikipedia articles through:
https://github.com/nodef/wikipedia-tts
Speaking Rate: 0.7570899205855142
Voice name: en-AU-Wavenet-D


"I cannot teach anybody anything, I can only make them think."
- Socrates


SUMMARY
=======
Biocon Limited (BSE: 532523) is an Indian biopharmaceutical company based in Bangalore, India. The Company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics, as well as, biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. In research services, Syngene International Limited (Syngene), a publicly listed subsidiary of Biocon, is engaged in the business of integrated end-to-end drug discovery and development services.
Biocon's formulations for the Indian market straddles Metabolics, Oncology, Immunotherapy, Nephrology and Specialty. Some of Biocon's key brands in India include INSUGEN (rh-insulin), BASALOG (Glargine), BIOMAb EGFR (Nimotuzumab), BLISTO (Glimepiride + Metformin), CANMAb (Trastuzumab), Evertor (Everolimus), TACROGRAF (Tacrolimus), ALZUMAb(Itolizumab) and KRABEVA (Bevacizumab), which are claimed to be considerably less expensive than other leading brands. Two of its novel programs on the verge of proof-of-concept stage are IN-105, which is the only oral insulin in the world to be in long duration clinical trials, and T1h, a novel humanised monoclonal antibody (MAb), the only first-in-class novel MAb being tested in India for rheumatoid arthritis and psoriasis.Biocon and Syngene together employ about 9200 personnel including biologists, chemists, medical practitioners, pharmacologists, engineers, finance/legal/marketing analysts, HR generalists and general administrators.